Aligos Therapeutics, Inc.【ALGS】

Market cap

$6.18M

P/E ratio

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	220	187	81	136	37
Restricted cash	560,000	0	0	0	0
Short-term investments	23	4	44	-	20
Other current assets	6	14	8	5	5
Total current assets	250	204	134	141	62
Operating lease right-of-use assets	7	9	8	7	5
Property and equipment, net	8	6	5	3	2
Other assets	0	1	1	1	1
Total assets	265	235	147	152	70
Accounts payable	3	3	5	3	3
Accrued liabilities	17	25	16	17	16
Operating Lease, Liability, Current	2	3	3	3	3
Finance Lease, Liability, Current	0	0	0	0	0
Deferred revenue, current	-	-	-	-	0
Total current liabilities	30	39	33	24	22
Operating Lease, Liability, Noncurrent	10	11	9	8	5
Finance Lease, Liability, Noncurrent	0	0	0	0	0
Common warrant liability	-	-	-	-	72
Long term liability	0	0	-	0	0
Total liabilities	45	51	43	59	99
Common Stock, Value, Issued	0	0	0	0	0
Additional paid-in capital	395	487	503	578	589
Accumulated deficit	-175	-303	-399	-487	-618
Accumulated other comprehensive income	-0	0	0	1	0
Total stockholders' (deficit) equity	220	185	104	92	-29
Total liabilities and stockholders' (deficit) equity	265	235	147	152	70